ystral was able to support the Waisenmedizin e.V. in the technical challenge of producing a medical gel for the treatment of leishmaniasis: in the conventional mixing process air is injected into the gel so that the wound to be treated is not sealed airtight. Therefore, a downstream degassing of the product would have to take place which however evaporates an active ingredient and makes the manufactured product ineffective.
Process plant for the fabrication of pharmaceutical gel
- Industry:
- Pharmaceutical industry
- End product:
Wound-healing gel
- Application:
Dispersing sodium chlorite and fillers in water
The customer requirements:
- Batch size: max. 10 l/Charge
- Space requirement: 9 m³
- Degree of automation: manual operation
- Powder feed: Powder hopper 20 l
- Cleanability: Wash in place (WIP) / manual
Advantages compared to the previous process:
During mixing of the solid and liquid ingredients air was introduced in the conventional process. These air entrapments avoided the "mechanical" effect of the gel which is why a downstream degassing process was necessary. In the degassing process an active ingredient evaporates, making the gel also ineffective.
- No air entry into the product scale-up from small quantities to production scale possible
- Laboratory scale batch sizes from 3l
- Maximum raw material utilization
- Minimum residual quantities
- All process parts can be easily dismantled for cleaning
- GMP compliant
- Licence to produce medical products/pharmaceuticals in a pharmacy
